Real-Time FO-SPR Monitoring of Solid-Phase DNAzyme Cleavage Activity for Cutting-Edge Biosensing
Source abstract
Abstract
DNA nanotechnology has a great potential in biosensor design including nanostructuring of the biosensor surface through DNA origami, target recognition by means of aptamers, and DNA-based signal amplification strategies. In this paper, we use DNA nanotechnology to describe for the first time the concept of real-time solid-phase monitoring of DNAzyme cleavage activity for the detection of specific single-stranded DNA (ssDNA) with a fiber optic surface plasmon resonance (FO-SPR) biosensor. Hereto, we first developed a robust ligation strategy for the functionalization of the FO-SPR biosensing surface with ssDNA-tethered gold nanoparticles, serving as the substrate for the DNAzyme. Next, we established a relation between the SPR signal change, due to the cleavage activity of the 10-23 DNAzyme, and the concentration of the DNAzyme, showing faster cleavage kinetics for higher DNAzyme concentrations. Finally, we implemented this generic concept for biosensing of ssDNA target in solution. Hereto, we designed a DNAzyme-inhibitor complex, consisting of an internal loop structure complementary to the ssDNA target, that releases active DNAzyme molecules in a controlled way as a function of the target concentration. We demonstrated reproducible target detection with a theoretical limit of detection of 1.4 nM, proving that the presented ligation strategy is key to a universal DNAzyme-based FO-SPR biosensing concept with promising applications in the medical and agrofood sector.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advanced biosensing and bioanalysis techniques · Plasmonic and Surface Plasmon Research · Biosensors and Analytical Detection
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Biosystems, Biosensors Group, KU Leuven, Willem de Croylaan 42, B-3001 Leuven, Belgium
Department of Materials Engineering, KU Leuven, Kasteelpark Arenberg 44, B-3001 Leuven, Belgium
FOx Biosystems NV, Veldstraat 120, B-9140 Temse, Belgium
Funding
KU Leuven · Fonds Wetenschappelijk Onderzoek
References (63)
Show source-provided references
1. 10.1038/344467a010.1038/344467a0 ↗
2. 10.1126/science.220012110.1126/science.2200121 ↗
3. 10.1038/346818a010.1038/346818a0 ↗
4. 10.1186/1556-276X-8-11910.1186/1556-276X-8-119 ↗
5. 10.1038/am.2013.2210.1038/am.2013.22 ↗
6. 10.3390/s12010061210.3390/s120100612 ↗
7. 10.1093/nar/gki93010.1093/nar/gki930 ↗
8. 10.1039/C4CC06855F10.1039/C4CC06855F ↗
9. 10.1021/acs.analchem.7b0492610.1021/acs.analchem.7b04926 ↗
10. 10.1016/S1074-5521(98)90006-010.1016/S1074-5521(98)90006-0 ↗
11. 10.1021/ac100095u10.1021/ac100095u ↗
12. 10.1021/ja031875r10.1021/ja031875r ↗
13. 10.1039/C0AN00557F10.1039/C0AN00557F ↗
14. 10.1021/ac035219l10.1021/ac035219l ↗
15. 10.1021/am506980d10.1021/am506980d ↗
16. 10.1021/ac300226910.1021/ac3002269 ↗
17. 10.1021/acs.analchem.6b0298810.1021/acs.analchem.6b02988 ↗
18. 10.1016/1074-5521(94)90014-010.1016/1074-5521(94)90014-0 ↗
19. 10.1073/pnas.94.9.426210.1073/pnas.94.9.4262 ↗
20. 10.1016/j.cbpa.2006.04.00310.1016/j.cbpa.2006.04.003 ↗
21. 10.1002/cbic.20070038410.1002/cbic.200700384 ↗
22. 10.1021/ja907677710.1021/ja9076777 ↗
23. 10.1021/ac501811r10.1021/ac501811r ↗
24. 10.1016/j.bios.2015.03.05710.1016/j.bios.2015.03.057 ↗
25. 10.1021/ja002131610.1021/ja0021316 ↗
26. 10.1002/1439-7633(20010601)2:6<411::AID-CBIC411>3.0.CO;2-I10.1002/1439-7633(20010601)2:6<411::AID-CBIC411>3.0.CO;2-I ↗
27. 10.1021/ja028123210.1021/ja0281232 ↗
28. 10.1021/ac034924r10.1021/ac034924r ↗
29. 10.1021/ac100904710.1021/ac1009047 ↗
30. 10.1016/j.bios.2010.04.01210.1016/j.bios.2010.04.012 ↗
31. 10.1007/s00604-016-1910-810.1007/s00604-016-1910-8 ↗
32. 10.1002/anie.20120871510.1002/anie.201208715 ↗
33. 10.1021/ja311367t10.1021/ja311367t ↗
34. 10.1016/j.bios.2016.01.04810.1016/j.bios.2016.01.048 ↗
35. 10.1016/j.bios.2010.09.01810.1016/j.bios.2010.09.018 ↗
36. 10.1021/acs.analchem.7b0352910.1021/acs.analchem.7b03529 ↗
37. 10.1021/ac040101610.1021/ac0401016 ↗
38. 10.1039/C4AN00922C10.1039/C4AN00922C ↗
39. 10.1021/am401027w10.1021/am401027w ↗
40. 10.1146/annurev.anchem.111808.07361710.1146/annurev.anchem.111808.073617 ↗
41. 10.1021/cr068107d10.1021/cr068107d ↗
42. 10.3390/s15051048110.3390/s150510481 ↗
43. 10.1007/s00216-014-8411-610.1007/s00216-014-8411-6 ↗
44. 10.1016/j.optlastec.2017.11.01510.1016/j.optlastec.2017.11.015 ↗
45. 10.1016/j.bios.2009.08.04510.1016/j.bios.2009.08.045 ↗
46. 10.1002/mabi.20110043510.1002/mabi.201100435 ↗
47. 10.1002/smll.20110220910.1002/smll.201102209 ↗
48. 10.3390/s1708175410.3390/s17081754 ↗
49. 10.1016/j.bios.2015.11.08710.1016/j.bios.2015.11.087 ↗
50. 10.1016/j.aca.2016.11.00510.1016/j.aca.2016.11.005 ↗
51. Todd A. V. · Clin. Chem. · 2000 · 46 · 62510.1093/clinchem/46.5.625 ↗
52. 10.1039/C7CC05445A10.1039/C7CC05445A ↗
53. 10.1021/ac061358210.1021/ac0613582 ↗
54. Rasband, W. S. ImageJ; U.S. National Institutes of Health: Bethesda, Maryland.
55. European Medicines Agency: CPMP/ICH/381/95 - ICH Topic Q2 (R1) Validation of Analytical Procedures: Text and Methodology Step 5 Note for Guidance on Validation of Analytical Procedures: Text and Methodology, 1995; July 2018.
56. 10.1021/ac980994010.1021/ac9809940 ↗
57. 10.1016/j.bios.2014.08.06710.1016/j.bios.2014.08.067 ↗
58. 10.1186/1556-276X-7-24110.1186/1556-276X-7-241 ↗
59. 10.1093/nar/gki59110.1093/nar/gki591 ↗
60. Markham N. R. · 2008 · 3
61. 10.1038/3502052410.1038/35020524 ↗
62. 10.1021/ac303008f10.1021/ac303008f ↗
63. 10.1039/C6CC00205F10.1039/C6CC00205F ↗